Skip to content
Political Economist

Political Economist

A liberal News reporting Politics, Sports, Business, Commentaries

  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Watch Online
  • Home
  • National News
  • Nigeria records 14,550 mild to moderate adverse reactions to vaccines, expects additional doses August – NPHCDA
  • National News

Nigeria records 14,550 mild to moderate adverse reactions to vaccines, expects additional doses August – NPHCDA

Admin July 14, 2021
covid-19 vaccines

July 14, 2021

Nigeria has recorded 14,550 of mild to moderate adverse reactions to the vaccines but no fatalities linked to the shots, the National Primary Health Care Development Agency (NPHCDA) said on Tuesday at a press briefing in Abuja .

Faisal Shuaib, head of the Agency also noted that the country expects to receive nearly 8 million additional doses of COVID-19 vaccines by the end of August, including from the U.S. government.

He added that Nigeria exhausted its initial supply of nearly 4 million shots last week and aims to resume vaccinations within weeks, when the new doses arrive.

“Nigeria expects delivery of 3.924 million doses of Oxford/AstraZeneca shots from global vaccine-sharing scheme COVAX by the end of July or early August, Shuaib said, and an additional 3.93 million doses of either Pfizer/Biotech or Moderna, donated by the U.S. government via COVAX, in August”.

He said Nigeria expects another 3.577 million doses of Pfizer/Biotech or Moderna from COVAX in the third quarter, as well as 29.85 million Johnson & Johnson shots purchased via the African Union, though he did not say when these would arrive.

The White House last month outlined a plan to share 55 million U.S. COVID-19 vaccine doses globally via COVAX.

  • Facebook
  • Share on X
  • LinkedIn
  • WhatsApp
  • Email
  • Copy Link
Tags: COVAX Moderna NPHCDA Oxford-Astrazeneca Pfizer/Biotech

Post navigation

Previous FG ‘ll be more intentional in seeking out investors – Osinbajo
Next NERC says 1.09m customers metered by DisCOs

Related Stories

Tinubu’s five-year strategic defence plan to end insecurity now ready, says Campaign Council 
  • National News

Tinubu’s five-year strategic defence plan to end insecurity now ready, says Campaign Council 

November 15, 2026
Army Recovers 12 Rifles, Rescues 10 Captives as Terrorists Initiate Surrender in Kwara Soldiers beat policemen
  • National News

Army Recovers 12 Rifles, Rescues 10 Captives as Terrorists Initiate Surrender in Kwara

November 14, 2026
Your life is a celebration of wisdom, leadership and royal excellence, says Ogeah on Asagba’s 71st birthday
  • National News

Your life is a celebration of wisdom, leadership and royal excellence, says Ogeah on Asagba’s 71st birthday

November 14, 2026

You may have missed

Tinubu’s five-year strategic defence plan to end insecurity now ready, says Campaign Council 
  • National News

Tinubu’s five-year strategic defence plan to end insecurity now ready, says Campaign Council 

November 15, 2026
Amaechi’s NDDC allegation: Public accountability requires evidence, not campaign declaration  Judicial Commissions indicts Amaechi
  • Press Releases

Amaechi’s NDDC allegation: Public accountability requires evidence, not campaign declaration 

November 15, 2026
Wike and Keyamo: Rabble rousers weaponising public for political relevance 
  • Press Releases

Wike and Keyamo: Rabble rousers weaponising public for political relevance 

November 15, 2026
Adebutu Vs INEC: Ogun APC guber aspirant, Hunye, hails court judgment, says ‘it’s victory for democracy’
  • Politics

Adebutu Vs INEC: Ogun APC guber aspirant, Hunye, hails court judgment, says ‘it’s victory for democracy’

November 15, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Copyright © All rights reserved. | DarkNews by AF themes.